A First Time in Human Study in Healthy Volunteers and Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Crohn's Disease

Interventions

DRUG

V565

single ascending dose of V565

DRUG

V565

Multiple dose

DRUG

Placebo

Single and multiple dose

DRUG

V565

Open-label single dose

DRUG

V565

Open-label single ascending dose

Trial Locations (1)

Quintiles Drug Research Unit at Guy's Hospital, Quintiles Ltd, London

All Listed Sponsors

lead

VHsquared Ltd.

INDUSTRY

NCT03010787 - A First Time in Human Study in Healthy Volunteers and Patients | Biotech Hunter | Biotech Hunter